vimarsana.com

இனப்பெருக்கம் உயிரியல் இல் ஹார்வர்ட் மருத்துவ பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Paramount Sourcing Names Dr Peter Rosenblatt as Chief Medical Officer

Share this article BOCA RATON, Fla., April 7, 2021 /PRNewswire/   Paramount Sourcing, the PPE distribution company, announced today that Dr. Peter Rosenblatt is Paramount Sourcing s new Chief Medical Officer. As an Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and Director of Urogynecology at Boston Urogynecology Associates and Mount Auburn Hospital, Dr. Rosenblatt brings more than 25 years of specialized medical experience to his new position at Paramount Sourcing. In order to address the immediate spike in demand for PPE caused by the COVID-19 pandemic, Paramount Sourcing s co-founders Brett Maugeri and Sean Perelstein created a new streamlined infrastructure designed for the transfer of masks, gowns, face shields and other vital equipment from production centers to hospitals and other essential businesses.

Pregnant women, infants more prone to severe risks of SARS-CoV-2-infection

Pregnant women, infants more prone to severe risks of SARS-CoV-2-infection ANI | Updated: Dec 27, 2020 22:25 IST Washington [US], December 27 (ANI): Research led by investigators at Massachusetts General Hospital (MGH) indicated the severe risk of COVID-19 followed SARS-CoV-2 infection into pregnant women and newborns. The study published in the journal Cell reveals lower than the expected transfer of protective SARS-CoV-2 antibodies via the placenta from mothers who are infected in the third trimester. The cause may be alterations to these antibodies after they re produced a process called glycosylation. The results expand on the team s recent findings published in JAMA Network Open that pregnant women with COVID-19 pass no SARS-CoV-2 virus, but also relatively low levels of antibodies against it, to newborns.

SARS-CoV-2 infection increases risk of severe COVID-19 in pregnant women, newborns

SARS-CoV-2 infection increases risk of severe COVID-19 in pregnant women, newborns Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection. New research led by investigators at Massachusetts General Hospital (MGH) and published in Cell reveals lower than expected transfer of protective SARS-CoV-2 antibodies via the placenta from mothers who are infected in the third trimester. The cause may be alterations to these antibodies after they re produced a process called glycosylation. The results expand on the team s recent findings published in JAMA Network Open that pregnant women with COVID-19 pass no SARS-CoV-2 virus, but also relatively low levels of antibodies against it, to newborns.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.